Dixon Hubard Feinour & Brown »

Halozyme Therapeutics shares owned by Dixon Hubard Feinour & Brown

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Dixon Hubard Feinour & Brown from 13F filings

Historical chart of Dixon Hubard Feinour & Brown investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Dixon Hubard Feinour & Brown consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Dixon Hubard Feinour & Brown

Quarter filed Position value Share count Share price at filing
2022-06-30 $890k 20k 44.02
2022-03-31 $806k 20k 39.87
2021-12-31 $805k 20k 40.21
2021-09-30 $772k 19k 40.70
2021-06-30 $634k 14k 45.39
2021-03-31 $367k 14k 26.27
2020-12-31 $367k 14k 26.27
2020-09-30 $367k 14k 26.27
2020-06-30 $380k 14k 27.21
2020-03-31 $251k 14k 17.97
2019-12-31 $248k 14k 17.75
2019-09-30 $217k 14k 15.54
2019-06-30 $271k 16k 17.19
2019-03-31 $269k 17k 16.11
2018-12-31 $244k 17k 14.61
2018-09-30 $303k 17k 18.14
2018-06-30 $282k 17k 16.88
2018-03-31 $338k 17k 19.61
2017-12-31 $349k 17k 20.25
2017-09-30 $312k 18k 17.39
2017-06-30 $230k 18k 12.82
2017-03-31 $233k 18k 12.98
2016-12-31 $177k 18k 9.86
2016-09-30 $217k 18k 12.09